Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Sullivan

Showing results (131-140 of 184) with videos related to

Pageof 19
Sort By:
Journal of the American Heart Association|June 29, 2022
B-Type Natriuretic Peptide and Long-Term Cardiovascular Mortality in Patients With Coronary Heart DiseaseRalph A H Stewart, Adrienne Kirby, Harvey D White, et al.
Cell Host & Microbe|August 12, 2008
Platelet factor 4 mediates inflammation in experimental cerebral malariaKalyan Srivastava, Ian A Cockburn, AnneMarie Swaim, et al.
Contemporary Clinical Trials|December 26, 2025
Clinical trial coordination of multifaceted ethical and regulatory oversight entities during the COVID-19 public health emergencyAmy Gawad, Jessica Mendoza, Megan Singleton, et al.
Diabetes Care|March 13, 2020
Incidence and Associations of Chronic Kidney Disease in Community Participants With Diabetes: A 5-Year Prospective Analysis of the EXTEND45 StudyLouisa Sukkar, Amy Kang, Carinna Hockham, et al.
European Heart Journal|February 26, 2008
The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID studyMalcolm J West, Paul J Nestel, Adrienne C Kirby, et al.
Nature Medicine|April 7, 2026
Zodasiran for cholesterol and triglyceride lowering in patients with hyperlipidemia: final report of phase 1 basket trialGerald F Watts, Russell Scott, David Sullivan, et al.
Circulation. Cardiovascular Quality and Outcomes|January 15, 2015
Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trialDavid Peiris, Tim Usherwood, Kathryn Panaretto, et al.
The Journal of Infectious Diseases|January 3, 2025
A Surrogate Enzyme-Linked Immunosorbent Assay to Select High-Titer Human Convalescent Plasma for Treating Immunocompromised Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 Variants of ConcernVictoria Dolange, Stefan Slamanig, Adam Abdeljawad, et al.
European Heart Journal|March 7, 2014
Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trialsEvan A Stein, Robert P Giugliano, Michael J Koren, et al.
BMJ Open|September 21, 2019
Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: protocol for the longitudinal, prospective, BioHEART-CT cohort studyKatharine A Kott, Stephen T Vernon, Thomas Hansen, et al.
Pageof 19

Showing results (131-140 of 184) with videos related to

Sort By:
Pageof 19
Journal of the American Heart Association|June 29, 2022
B-Type Natriuretic Peptide and Long-Term Cardiovascular Mortality in Patients With Coronary Heart DiseaseRalph A H Stewart, Adrienne Kirby, Harvey D White, et al.
Cell Host & Microbe|August 12, 2008
Platelet factor 4 mediates inflammation in experimental cerebral malariaKalyan Srivastava, Ian A Cockburn, AnneMarie Swaim, et al.
Contemporary Clinical Trials|December 26, 2025
Clinical trial coordination of multifaceted ethical and regulatory oversight entities during the COVID-19 public health emergencyAmy Gawad, Jessica Mendoza, Megan Singleton, et al.
Diabetes Care|March 13, 2020
Incidence and Associations of Chronic Kidney Disease in Community Participants With Diabetes: A 5-Year Prospective Analysis of the EXTEND45 StudyLouisa Sukkar, Amy Kang, Carinna Hockham, et al.
European Heart Journal|February 26, 2008
The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID studyMalcolm J West, Paul J Nestel, Adrienne C Kirby, et al.
Nature Medicine|April 7, 2026
Zodasiran for cholesterol and triglyceride lowering in patients with hyperlipidemia: final report of phase 1 basket trialGerald F Watts, Russell Scott, David Sullivan, et al.
Circulation. Cardiovascular Quality and Outcomes|January 15, 2015
Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trialDavid Peiris, Tim Usherwood, Kathryn Panaretto, et al.
The Journal of Infectious Diseases|January 3, 2025
A Surrogate Enzyme-Linked Immunosorbent Assay to Select High-Titer Human Convalescent Plasma for Treating Immunocompromised Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 Variants of ConcernVictoria Dolange, Stefan Slamanig, Adam Abdeljawad, et al.
European Heart Journal|March 7, 2014
Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trialsEvan A Stein, Robert P Giugliano, Michael J Koren, et al.
BMJ Open|September 21, 2019
Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: protocol for the longitudinal, prospective, BioHEART-CT cohort studyKatharine A Kott, Stephen T Vernon, Thomas Hansen, et al.
Pageof 19